Literature DB >> 6403361

Interferon-gamma production by Listeria monocytogenes-specific T cells active in cellular antibacterial immunity.

S H Kaufmann, H Hahn, R Berger, H Kirchner.   

Abstract

Cultures of peritoneal exudate T lymphocyte-enriched cells (PETLEC) from Listeria monocytogenes-immune mice, antigen-presenting cells (APC) and heat-killed L. monocytogenes produced high amounts of interferon-gamma (IFN-gamma). High IFN titers were also observed after stimulation of L. monocytogenes-immune cell cultures with the T cell mitogens concanavalin A and phytohemagglutinin. L. monocytogenes-immune PETLEC produced several fold higher IFN titers than normal cell cultures in response to mitogen and antigen. Under both circumstances, APC were required for optimum responses. L. monocytogenes-immune PETLEC participating in IFN production were Lyt 1+23-. IFN-gamma was also produced in cultures of cloned L. monocytogenes-specific T cells. Since the same T cell clone showed antigen-specific proliferative responses and interleukin production in vitro, and could adoptively mediate delayed-type hypersensitivity and anti-listerial protection in vivo, it is suggested that IFN production is a function of specific T cells active in cellular antibacterial immunity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403361     DOI: 10.1002/eji.1830130318

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  30 in total

1.  Function and antigen recognition pattern of L3T4+ T-cell clones from Mycobacterium tuberculosis-immune mice.

Authors:  S H Kaufmann; I Flesch
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

2.  Difference in the induction of macrophage interleukin-1 production between viable and killed cells of Listeria monocytogenes.

Authors:  M Mitsuyama; K Igarashi; I Kawamura; T Ohmori; K Nomoto
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

3.  Disruption of the cellular inflammatory response to Listeria monocytogenes infection in mice with disruptions in targeted genes.

Authors:  J DiTirro; E R Rhoades; A D Roberts; J M Burke; A Mukasa; A M Cooper; A A Frank; W K Born; I M Orme
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Active and memory immunity to Listeria monocytogenes infection in mice is mediated by phenotypically distinct T-cell populations.

Authors:  I M Orme
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

5.  Parasite exposure elicits a preferential T-cell response involved in protective immunity against Eimeria species in chickens primed by an internal-image anti-idiotypic antibody.

Authors:  B S Bhogal; E B Jacobson; H Y Tse; D M Schmatz; O J Ravino
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

6.  Restricted replication of Listeria monocytogenes in a gamma interferon-activated murine hepatocyte line.

Authors:  G Szalay; J Hess; S H Kaufmann
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

7.  Pathogenicity and immunogenicity of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread.

Authors:  R A Barry; H G Bouwer; D A Portnoy; D J Hinrichs
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Production of macrophage-activating and migration-inhibition factors in vitro by serologically selected and cloned Listeria monocytogenes-specific T cells of the Lyt 1+2- phenotype.

Authors:  U Sperling; S H Kaufmann; H Hahn
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

9.  Acquired resistance to facultative intracellular bacteria: relationship between persistence, cross-reactivity at the T-cell level, and capacity to stimulate cellular immunity of different Listeria strains.

Authors:  S H Kaufmann
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

10.  Antigen-specific T-cell responses during primary and secondary Listeria monocytogenes infection.

Authors:  S Daugelat; C H Ladel; B Schoel; S H Kaufmann
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.